- T
The Termeer Foundation
- Alison Lawton
Alison Lawton serves as the Chair of the Board of Directors at Dianthus Therapeutics, Inc. since September 2023 and is a current board member at BlueRock Therapeutics, X4 Pharmaceuticals, and ProQR Therapeutics NV. Lawton's past roles include Chair and board member at Magenta Therapeutics and president & CEO of Kaleido Biosciences. Additionally, Lawton holds a board position at Verastem and previously served on the board of Aeglea BioTherapeutics and Spyre Therapeutics. Lawton earned a BSc Hons in Pharmacology from King’s College London between 1981 and 1984.
Org chart
This person is not in the org chart
Teams
Offices
The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation is a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines.
